Evidence map›Paper›PMID 32124265›Full record

ArticleJournal of neurovirology2020

Investigation of simian virus 40 (SV40) and human JC, BK, MC, KI, and WU polyomaviruses in glioma.

Sarra Limam, Nabiha Missaoui, Ahlem Bdioui, Mohamed Taher Yacoubi, Hedi Krifa, Moncef Mokni, Boulbeba Selmi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Signaling pathways in brain tumors and therapeutic interventions.Signal transduction and targeted therapy · 2023
    Review
  6. Article
  7. Article
  8. Epidemiology of Brain and Other CNS Tumors.Current neurology and neuroscience reports · 2021
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sarra LimamPathology Department, Farhet Hached University Hospital, 4000, Sousse, Tunisia.
Nabiha MissaouiFaculty of Sciences and Techniques of Sidi Bouzid, Kairouan University, Kairouan, Tunisia. missaouinabiha@live.fr.ORCID 0000-0001-6964-075X
Ahlem BdiouiPathology Department, Farhet Hached University Hospital, 4000, Sousse, Tunisia.
Mohamed Taher YacoubiPathology Department, Farhet Hached University Hospital, 4000, Sousse, Tunisia.
Hedi KrifaNeurosurgery Department, Sahloul University Hospital, 4000, Sousse, Tunisia.
Moncef MokniPathology Department, Farhet Hached University Hospital, 4000, Sousse, Tunisia.
Boulbeba SelmiLaboratory of Bioresources, Integrative Biology and Exploiting, ISB, 5000, Monastir, Tunisia.
Hôpital Farhat Hached · TNHôpital Sahloul · TNUniversity of Kairouan · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gliomagenesis remains not fully established and their etiological factors still remain obscure. Polyomaviruses were detected and involved in several human tumors. Their potential implication in gliomas has been not yet surveyed in Africa and Arab World. Herein, we investigated the prevalence of six polyomaviruses (SV40, JCPyV, BKPyV, MCPyV, KIPyV, and WUPyV) in 112 gliomas from Tunisian patients. The DNA sequences of polyomaviruses were examined by PCR assays. Viral infection was confirmed by DNA in situ hybridization (ISH) and/or immunohistochemistry (IHC). The relationships between polyomavirus infection and tumor features were evaluated. Specific SV40 Tag, viral regulatory, and VP1 regions were identified in 12 GBM (10.7%). DNA ISH targeting the whole SV40 genome and SV40 Tag IHC confirmed the PCR findings. Five gliomas yielded JCPyV positivity by PCR and DNA ISH (2.7%). However, no BKPyV, KIPyV, and WUPyV DNA sequences were identified in all samples. MCPyV DNA was identified in 30 gliomas (26.8%). For GBM samples, MCPyV was significantly related to patient age (p = 0.037), tumor recurrence (p = 0.024), and SV40 (p = 0.045) infection. No further significant association was identified with the remaining tumor features (p > 0.05) and patient survival (Log Rank, p > 0.05). Our study indicates the presence of SV40, JCPyV, and MCPyV DNA in Tunisian gliomas. Further investigations are required to more elucidate the potential involvement of polyomaviruses in these destructive malignancies.

Indexed as

AdultAge FactorsBrain NeoplasmsCapsid ProteinsDNA, ViralFemaleFollow-Up StudiesGliomaHumansImmunohistochemistryIn Situ HybridizationJC VirusMaleMerkel cell polyomavirusMiddle AgedNeoplasm GradingCapsid ProteinsDNA, ViralVP1 protein, polyomavirusGlioblastomaGliomaInfectionJCPyVMCPyVSV40

Identifiers

PMID32124265
OpenAlexW3009062840

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.